Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort UD in Ocular Hypertensive or Glaucomatous Patients.

  • STATUS
    Recruiting
  • days left to enroll
    60
  • participants needed
    500
  • sponsor
    Laboratoires Thea
Updated on 31 May 2021

Summary

To demonstrate the non-inferiority of T4030 unpreserved eye drops compared to Ganfort UD in terms of efficacy.

Description

Efficacy Parameters IOP assessment in each eye

Details
Condition Ocular Hypertension Glaucoma
Treatment Bimatoprost Timolol (T4030), Bimatoprost Timolol (Ganfort)
Clinical Study IdentifierNCT04898387
SponsorLaboratoires Thea
Last Modified on31 May 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Informed consent signed and dated
Patient aged 18 years old
Both eyes with a central corneal thickness assessment 500 m and 600 m a
Both eyes with diagnosed ocular hypertension or open angle glaucoma

Exclusion Criteria

History of narrow angle and/or angle closure glaucoma
Advanced stage of glaucoma
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note